L-type Ca2+ channel blockers inhibit the window contraction of mouse aorta segments with high affinity

Cédéric F Michiels1, Cor E Van Hove2, Wim Martinet1

  • 1Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.

Insights

L-type calcium channel blockers (LCCBs) effectively inhibit non-inactivating calcium channels, contributing to their anti-hypertensive effects. These blockers preferentially target vascular smooth muscle, reducing blood pressure by blocking crucial calcium influx.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Molecular Biology

Background:

  • L-type calcium channel blockers (LCCBs) are more effective in hypertensive individuals and vascular smooth muscle (VSM) than normotensive subjects or cardiac muscle.
  • This differential efficacy is attributed to the depolarized resting potential in VSM and hypertension, favoring the high-affinity inactivated state of L-type calcium channels (LCCs).
  • However, depolarized potentials also increase Ca(2+) influx through window, non-inactivating LCCs.

Purpose of the Study:

  • To investigate the efficacy of nifedipine, verapamil, and diltiazem in blocking window, non-inactivating LCCs.
  • To elucidate the role of these channels in VSM contractions and their sensitivity to LCCBs.

Main Methods:

  • C57Bl6 mouse aortic segments were depolarized using 50mM K(+) to induce inactivation.
  • Biphasic contractions were analyzed, and the sensitivity of fast and slow force components to LCCBs was assessed.
  • The effects of removing the fast force component and stimulating Ca(2+) influx with BAY K8644 on LCCB efficacy were examined.

Main Results:

  • Depolarization evoked biphasic contractions, with the slow force component showing higher sensitivity to LCCBs.
  • Removal of the fast force component enhanced LCCB efficacy, while BAY K8644 decreased it.
  • LCCBs induced concentration-dependent relaxation, independent of the fast force component, but with reduced sensitivity when BAY K8644 was present.

Conclusions:

  • Steady-state contractions induced by 50mM K(+) depolarization are primarily mediated by window Ca(2+) influx, which is effectively inhibited by LCCBs.
  • Interactions between LCCB receptors, Ca(2+) ions, and BAY K8644 influence LCCB efficacy.
  • The high affinity of LCCBs for open, non-inactivating LCCs likely plays a significant role in their anti-hypertensive actions.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.7K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.9K